Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan, Notification of Proposed Production Activity, Pfizer, Inc., (Pharmaceutical Products), Kalamazoo, Michigan, 26433-26434 [2017-11835]

Download as PDF Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices H. Other Information BROADCASTING BOARD OF GOVERNORS Non Discrimination Statement sradovich on DSK3GMQ082PROD with NOTICES In accordance with Federal civil rights law and U.S. Department of Agriculture (USDA) civil rights regulations and policies, the USDA, its Agencies, offices, and employees, and institutions participating in or administering USDA programs are prohibited from discriminating based on race, color, national origin, religion, sex, gender identity (including gender expression), sexual orientation, disability, age, marital status, family/ parental status, income derived from a public assistance program, political beliefs, or reprisal or retaliation for prior civil rights activity, in any program or activity conducted or funded by USDA (not all bases apply to all programs). Remedies and complaint filing deadlines vary by program or incident. Persons with disabilities who require alternative means of communication for program information (e.g., Braille, large print, audiotape, American Sign Language, etc.) should contact the responsible Agency or USDA’s TARGET Center at (202) 720–2600 (voice and TTY) or contact USDA through the Federal Relay Service at (800) 877–8339. Additionally, program information may be made available in languages other than English. To file a program discrimination complaint, complete the USDA Program Discrimination Complaint Form, AD– 3027, found online at https:// www.ascr.usda.gov/complaint_filing_ cust.html and at any USDA office or write a letter addressed to USDA and provide in the letter all of the information requested in the form. To request a copy of the complaint form, call (866) 632–9992. Submit your completed form or letter to USDA by: (1) Mail: U.S. Department of Agriculture, Office of the Assistant Secretary for Civil Rights, 1400 Independence Avenue SW., Washington, DC 20250–9410; (2) Fax: (202) 690–7442; or (3) Email: program.intake@usda.gov. Dated: May 26, 2017. Chadwick O. Parker, Acting Administrator, Rural BusinessCooperative Service. [FR Doc. 2017–11739 Filed 6–6–17; 8:45 am] BILLING CODE 3410–XY–P VerDate Sep<11>2014 16:37 Jun 06, 2017 Jkt 241001 Request for Comments on the Broadcasting Board of Governors’ Implementation of a Comprehensive Plan for Reorganizing the Executive Branch Broadcasting Board of Governors (BBG). ACTION: Request for comments. AGENCY: Executive Order 13781, ‘‘Comprehensive Plan for Reorganizing the Executive Branch,’’ signed into effect on March 13, 2017, directs the Director of the Office of Management and Budget (OMB) to present the President with a plan that recommends ways to reorganize the executive branch and eliminate unnecessary agencies. As part of this process, the Broadcasting Board of Governors will be submitting a proposal for reorganization to OMB. This request for comments seeks public input on potential reforms at the BBG that would increase the efficiency, effectiveness, and accountability of the agency. These comments will also be considered in the development of the BBG’s 2018–2022 Strategic Plan. The BBG is the federal agency charged with carrying out U.S. Government funded international media, overseeing the operations of five media networks: the Voice of America (VOA), Radio and TV Marti, Radio Free Europe/Radio Liberty (RFE/RL), Radio Free Asia (RFA), and the Middle East Broadcasting Networks (MBN). DATES: Submit either electronic comments or information by June 30, 2017. We will not accept comments by fax or paper delivery. ADDRESSES: Submit comments through the BBG Web site at https:// www.bbg.gov/submit-your-ideas/. FOR FURTHER INFORMATION CONTACT: Matt Ciepielowski at 202–203–4845. SUPPLEMENTARY INFORMATION: Through this request for comments, the BBG is seeking initial feedback from a broad range of stakeholders on questions that will contribute to the BBG’s proposal to OMB in accordance with Executive Order 13781 and the BBG’s 2018–2022 Strategic Plan. This request for comments is for information-gathering and fact-finding purposes only, and should not be construed as a solicitation or as an obligation on the part of the BBG to agree with submitted comments or to make recommendations regarding specific issues identified in public comments. The BBG requests that respondents generally address the following overarching questions: SUMMARY: PO 00000 Frm 00011 Fmt 4703 Sfmt 4703 26433 • What are the most important or effective projects or programs that the BBG undertakes? • Do you think that there are any changes that BBG could make to increase the efficiency, effectiveness, and accountability of its media networks or the agency itself? If so, please describe those changes. • Would you propose reorganizing any parts or aspects of the BBG or its media networks to increase efficiency, effectiveness, and accountability? If so, how? • In today’s changing media landscape, how should the BBG adapt to best serve its mission to inform, engage, and connect people around the world in support of freedom and democracy? Oanh Tran, Director of Board Operations, Broadcasting Board of Governors. [FR Doc. 2017–11832 Filed 6–6–17; 8:45 am] BILLING CODE 86100–01–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–27–2017] Foreign-Trade Zone (FTZ) 43—Battle Creek, Michigan, Notification of Proposed Production Activity, Pfizer, Inc., (Pharmaceutical Products), Kalamazoo, Michigan Pfizer Inc. (Pfizer) submitted a notification of proposed production activity to the FTZ Board for its facility in Kalamazoo, Michigan within Subzone 43E. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on April 12, 2017. Pfizer already has authority to produce certain pharmaceutical products within Subzone 43E. The current request would add finished products and a foreign status material/ component to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreign-status material/component and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Pfizer from customs duty payments on the foreign-status material/ components used in export production. On its domestic sales, Pfizer would be able to choose the duty rate during customs entry procedures that apply to crisaborole (EucrisaTM) (duty free) in finished product and bulk form for the E:\FR\FM\07JNN1.SGM 07JNN1 26434 Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices foreign-status material/component noted below and in the existing scope of authority. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The material/component sourced from abroad is crisaborole—active pharmaceutical ingredient (duty rate 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is July 17, 2017. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov or (202) 482–1963. Dated: June 2, 2017. Andrew McGilvray, Executive Secretary. [FR Doc. 2017–11835 Filed 6–6–17; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Dated: June 2, 2017. Andrew McGilvray, Executive Secretary. [B–26–2017] sradovich on DSK3GMQ082PROD with NOTICES Foreign-Trade Zone (FTZ) 80—San Antonio, Texas, Notification of Proposed Production Activity, DPT Laboratories, Ltd., (Pharmaceutical Products), San Antonio, Texas [FR Doc. 2017–11833 Filed 6–6–17; 8:45 am] BILLING CODE 3510–DS–P DPT Laboratories, Ltd. (DPT) submitted a notification of proposed production activity to the FTZ Board for its facilities in San Antonio, Texas. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on April 17, 2017. The request indicates that a separate application for subzone designation for two DPT facilities under FTZ 80 will be submitted. Any such application would be processed under Section 400.38 of the Board’s regulations. The facilities will be used to produce certain pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status material/component and specific finished products described in the submitted notification (as described VerDate Sep<11>2014 16:37 Jun 06, 2017 Jkt 241001 below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt DPT from customs duty payments on the foreign-status material/ componens used in export production. On its domestic sales, DPT would be able to choose the duty rate during customs entry procedures that apply to crisaborole (EucrisaTM) (duty free) in finished product and bulk form for the foreign-status input noted below. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The material/component sourced from abroad is crisaborole—active pharmaceutical ingredient (duty rate 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is July 17, 2017. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov or (202) 482–1963. DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–28–2017] Foreign-Trade Zone 186—Waterville, Maine Application for Production Authority, Flemish Master Weavers, Subzone 186A, (Machine-Made Woven Area Rugs), Sanford, Maine An application has been submitted to the Foreign-Trade Zones (FTZ) Board by the City of Waterville, Maine, grantee of FTZ 186, requesting production authority on behalf of Flemish Master Weavers (FMW), located within Subzone 186A in Sanford, Maine. The application conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.23) was docketed on April 18, 2017. PO 00000 Frm 00012 Fmt 4703 Sfmt 9990 The FMW facility (127 employees, 4.08 acres) is used for the production of machine-made woven area rugs. FMW already has restricted FTZ authority to produce area rugs using polypropylene and polyester yarns in privileged foreign status (19 CFR 146.41), which precludes inverted tariff benefits on those inputs (see 81 FR 51850, August 5, 2016). The pending application requests authority for FMW to use imported continuous filament polypropylene yarn in non-privileged foreign status (19 CFR 146.42). If the application were approved, on its domestic sales, FMW would be able to choose the duty rate during customs entry procedures that applies to machine-made woven area rugs (duty free) for the imported continuous filament polypropylene yarn (otherwise dutiable at 8%). Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The request indicates that the savings from FTZ procedures would help improve the plant’s international competitiveness. In accordance with the FTZ Board’s regulations, Diane Finver of the FTZ Staff is designated examiner to evaluate and analyze the facts and information presented in the application and case record and to report findings and recommendations to the FTZ Board. Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is August 7, 2017. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to August 21, 2017. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: June 2, 2017. Andrew McGilvray, Executive Secretary. [FR Doc. 2017–11837 Filed 6–6–17; 8:45 am] BILLING CODE 3510–DS–P E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 82, Number 108 (Wednesday, June 7, 2017)]
[Notices]
[Pages 26433-26434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11835]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-27-2017]


Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan, Notification 
of Proposed Production Activity, Pfizer, Inc., (Pharmaceutical 
Products), Kalamazoo, Michigan

    Pfizer Inc. (Pfizer) submitted a notification of proposed 
production activity to the FTZ Board for its facility in Kalamazoo, 
Michigan within Subzone 43E. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on April 12, 2017.
    Pfizer already has authority to produce certain pharmaceutical 
products within Subzone 43E. The current request would add finished 
products and a foreign status material/component to the scope of 
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would 
be limited to the specific foreign-status material/component and 
specific finished products described in the submitted notification (as 
described below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Pfizer from customs 
duty payments on the foreign-status material/components used in export 
production. On its domestic sales, Pfizer would be able to choose the 
duty rate during customs entry procedures that apply to crisaborole 
(EucrisaTM) (duty free) in finished product and bulk form 
for the

[[Page 26434]]

foreign-status material/component noted below and in the existing scope 
of authority. Customs duties also could possibly be deferred or reduced 
on foreign-status production equipment.
    The material/component sourced from abroad is crisaborole--active 
pharmaceutical ingredient (duty rate 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is July 17, 2017.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
Chris.Wedderburn@trade.gov or (202) 482-1963.

    Dated: June 2, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017-11835 Filed 6-6-17; 8:45 am]
 BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.